FEMZOLE 2.5mg Tablet contains Letrozole 2.5 mg. It is an aromatase inhibitor used to treat hormone receptor-positive breast cancer in postmenopausal women by reducing estrogen production in the body.
Uses:
Treatment of hormone receptor-positive early breast cancer in postmenopausal women.
Treatment of advanced or metastatic breast cancer.
Adjuvant therapy after surgery for breast cancer.
Ovulation induction in women with infertility as prescribed by a physician.
Dose:
Adults: Usually 2.5 mg once daily, or as directed by a physician.
Take the medicine exactly as prescribed by a healthcare professional.
Dose and duration depend on the patient's condition, indication, and response to treatment.